
Diffuse Bio is a company leveraging generative AI for protein design, aiming to revolutionize protein therapeutics development. Their technology allows for the design of novel protein binders with unprecedented control and accuracy, significantly faster than traditional lab methods. Their primary product, DiffuseSandbox, provides researchers with AI models like DSG2-mini for protein binder design, with a focus on nanobody design initially. They claim a ~3% hit rate for their AI-designed nanobodies, orders of magnitude better than industry standards, and can design strong binders with affinities <=10nM. Diffuse Bio's mission is to accelerate protein discovery and development through advanced AI and data at scale.

Diffuse Bio is a company leveraging generative AI for protein design, aiming to revolutionize protein therapeutics development. Their technology allows for the design of novel protein binders with unprecedented control and accuracy, significantly faster than traditional lab methods. Their primary product, DiffuseSandbox, provides researchers with AI models like DSG2-mini for protein binder design, with a focus on nanobody design initially. They claim a ~3% hit rate for their AI-designed nanobodies, orders of magnitude better than industry standards, and can design strong binders with affinities <=10nM. Diffuse Bio's mission is to accelerate protein discovery and development through advanced AI and data at scale.